KUSH PARMAR Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for KUSH PARMAR.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of KUSH PARMAR. KUSH PARMAR is Director in scPharmaceuticals Inc. ($SCPH) and Director in Audentes Therapeutics, Inc. ($BOLD) and Director in ARVINAS, INC. ($ARVN) and Director in Homology Medicines, Inc. ($FIXX) and Director in Akouos, Inc. ($AKUS) and Director in Vor Biopharma Inc. ($VOR) and Co-CEO in 5:01 Acquisition Corp. ($FVAM).

Latest Insider Trading Transactions of KUSH PARMAR

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, FVAM, AKUS, ARVN, BOLD, FIXX, SCPH, VOR

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Feb 09 2021	VOR	Vor Biopharma Inc.	PARMAR KUSH	Director	Option Exercise	C	0.00	19,230,768	0	0
Feb 09 2021	VOR	Vor Biopharma Inc.	PARMAR KUSH	Director	Option Exercise	C	0.00	19,230,768	0	0
Feb 09 2021	VOR	Vor Biopharma Inc.	PARMAR KUSH	Director	Option Exercise	C	0.00	45,000,000	0	0
Feb 09 2021	VOR	Vor Biopharma Inc.	PARMAR KUSH	Director	Option Exercise	A	18.00	16,900	304,200	16,900
Feb 09 2021	VOR	Vor Biopharma Inc.	PARMAR KUSH	Director	Buy	P	18.00	444,444	7,999,992	1,858,470	1.4 M to 1.9 M (+31.43 %)
Feb 09 2021	VOR	Vor Biopharma Inc.	PARMAR KUSH	Director	Buy	C	0.00	1,414,026	0	1,414,026	0 to 1.4 M
Feb 09 2021	VOR	Vor Biopharma Inc.	PARMAR KUSH	Director	Buy	P	18.00	111,111	1,999,998	4,833,959	4.7 M to 4.8 M (+2.35 %)
Feb 09 2021	VOR	Vor Biopharma Inc.	PARMAR KUSH	Director	Buy	C	0.00	1,414,026	0	4,722,848	3.3 M to 4.7 M (+42.74 %)
Feb 09 2021	VOR	Vor Biopharma Inc.	PARMAR KUSH	Director	Buy	C	0.00	3,308,822	0	3,308,822	0 to 3.3 M
Dec 31 2020	AKUS	Akouos, Inc.	PARMAR KUSH	Director	Sell	S	18.00	111,648	2,009,664	982,453	1.1 M to 982.5 K (-10.20 %)
Dec 31 2020	AKUS	Akouos, Inc.	PARMAR KUSH	Director	Sell	S	18.00	111,648	2,009,664	982,453	1.1 M to 982.5 K (-10.20 %)
Dec 31 2020	AKUS	Akouos, Inc.	PARMAR KUSH	Director	Sell	S	18.00	358,352	6,450,336	3,153,331	3.5 M to 3.2 M (-10.20 %)
Dec 31 2020	AKUS	Akouos, Inc.	PARMAR KUSH	Director	Sell	S	18.00	358,352	6,450,336	3,153,331	3.5 M to 3.2 M (-10.20 %)
Dec 28 2020	FIXX	Homology Medicines ...	PARMAR KUSH	Director	Sell	S	12.82	20,000	256,400	181,435	201.4 K to 181.4 K (-9.93 %)
Dec 28 2020	FIXX	Homology Medicines ...	PARMAR KUSH	Director	Sell	S	12.82	480,000	6,153,600	4,354,484	4.8 M to 4.4 M (-9.93 %)
Dec 16 2020	FIXX	Homology Medicines ...	PARMAR KUSH	Director	Sell	S	11.88	13,703	162,792	201,435	215.1 K to 201.4 K (-6.37 %)
Dec 16 2020	FIXX	Homology Medicines ...	PARMAR KUSH	Director	Sell	S	13.06	6,297	82,244	215,138	221.4 K to 215.1 K (-2.84 %)
Dec 16 2020	FIXX	Homology Medicines ...	PARMAR KUSH	Director	Sell	S	11.88	328,862	3,906,881	4,834,484	5.2 M to 4.8 M (-6.37 %)
Dec 16 2020	FIXX	Homology Medicines ...	PARMAR KUSH	Director	Sell	S	13.06	151,138	1,973,998	5,163,346	5.3 M to 5.2 M (-2.84 %)
Dec 01 2020	FVAM	5:01 Acquisition C ...	PARMAR KUSH	Co-CEO	Option Exercise	J	0.00	235,932	0	1,944,068
Nov 12 2020	FVAM	5:01 Acquisition C ...	PARMAR KUSH	Co-CEO	Buy	J	10.00	5,126	51,260	365,126	360 K to 365.1 K (+1.42 %)
Jul 02 2020	AKUS	Akouos, Inc.	PARMAR KUSH	Director	Option Exercise	C	0.00	16,858,076	0	0
Jul 02 2020	AKUS	Akouos, Inc.	PARMAR KUSH	Director	Option Exercise	C	0.00	21,072,595	0	0
Jul 02 2020	AKUS	Akouos, Inc.	PARMAR KUSH	Director	Option Exercise	C	0.00	42,102,730	0	0
Jul 02 2020	AKUS	Akouos, Inc.	PARMAR KUSH	Director	Option Exercise	C	0.00	10,826,417	0	0
Jul 02 2020	AKUS	Akouos, Inc.	PARMAR KUSH	Director	Buy	P	17.00	294,117	4,999,989	1,094,101	800 K to 1.1 M (+36.77 %)
Jul 02 2020	AKUS	Akouos, Inc.	PARMAR KUSH	Director	Buy	C	0.00	799,984	0	799,984	0 to 800 K
Jul 02 2020	AKUS	Akouos, Inc.	PARMAR KUSH	Director	Buy	C	0.00	999,980	0	3,511,683	2.5 M to 3.5 M (+39.81 %)
Jul 02 2020	AKUS	Akouos, Inc.	PARMAR KUSH	Director	Buy	C	0.00	1,997,946	0	2,511,703	513.8 K to 2.5 M (+388.89 %)
Jul 02 2020	AKUS	Akouos, Inc.	PARMAR KUSH	Director	Buy	C	0.00	513,757	0	513,757	0 to 513.8 K
Jun 12 2020	FIXX	Homology Medicines ...	PARMAR KUSH	Director	Option Exercise	A	16.32	18,000	293,760	18,000
Sep 26 2019	ARVN	ARVINAS, INC.	PARMAR KUSH	Director	Gift	G	0.00	1,700	0	1,775	3.5 K to 1.8 K (-48.92 %)
Sep 18 2019	ARVN	ARVINAS, INC.	PARMAR KUSH	Director	Buy	J	0.00	3,475	0	3,475	0 to 3.5 K
Sep 18 2019	ARVN	ARVINAS, INC.	PARMAR KUSH	Director	Buy	J	0.00	3,475	0	3,475	0 to 3.5 K
Jun 10 2019	FIXX	Homology Medicines ...	PARMAR KUSH	Director	Option Exercise	A	19.51	15,580	303,966	15,580
May 28 2019	ARVN	ARVINAS, INC.	PARMAR KUSH	Director	Option Exercise	A	22.06	12,923	285,081	12,923
May 20 2019	FIXX	Homology Medicines ...	PARMAR KUSH	Director	Sell	S	21.47	24,600	528,162	221,435	246 K to 221.4 K (-10.00 %)
May 20 2019	FIXX	Homology Medicines ...	PARMAR KUSH	Director	Sell	S	21.47	590,400	12,675,888	5,314,484	5.9 M to 5.3 M (-10.00 %)
Dec 12 2018	FIXX	Homology Medicines ...	PARMAR KUSH	Director	Sell	S	26.01	623	16,201	246,035	246.7 K to 246 K (-0.25 %)
Dec 12 2018	FIXX	Homology Medicines ...	PARMAR KUSH	Director	Sell	S	26.01	14,952	388,828	5,904,884	5.9 M to 5.9 M (-0.25 %)
Nov 27 2018	FIXX	Homology Medicines ...	PARMAR KUSH	Director	Sell	S	20.04	1,187	23,783	246,658	247.8 K to 246.7 K (-0.48 %)
Nov 27 2018	FIXX	Homology Medicines ...	PARMAR KUSH	Director	Sell	S	20.04	28,495	570,926	5,919,836	5.9 M to 5.9 M (-0.48 %)
Nov 20 2018	FIXX	Homology Medicines ...	PARMAR KUSH	Director	Sell	S	20.20	21,036	424,927	247,845	268.9 K to 247.8 K (-7.82 %)
Nov 20 2018	FIXX	Homology Medicines ...	PARMAR KUSH	Director	Sell	S	20.20	504,864	10,198,253	5,948,331	6.5 M to 5.9 M (-7.82 %)
Jun 21 2018	SCPH	scPharmaceuticals ...	PARMAR KUSH	Director	Option Exercise	A	5.53	6,124	33,866	6,124
Jun 08 2018	BOLD	Audentes Therapeut ...	PARMAR KUSH	Director	Option Exercise	A	38.65	10,000	386,500	10,000
Mar 29 2018	FIXX	Homology Medicines ...	PARMAR KUSH	Director	Option Exercise	A	16.00	31,160	498,560	31,160
Oct 10 2017	BOLD	Audentes Therapeut ...	PARMAR KUSH	Director	Option Exercise	A	26.01	9,000	234,090	9,000
Aug 25 2016	BOLD	Audentes Therapeut ...	PARMAR KUSH	Director	Option Exercise	A	15.03	18,000	270,540	18,000

Page: 1